targeted cancer therapy: choosing the right assay to assess parp inhibitors
Published 1 year ago • 372 plays • Length 44:25Download video MP4
Download video MP3
Similar videos
-
47:59
advances and challenges in targeting kinases in cancer therapeutics
-
7:25
understanding the biological targets of parp inhibitors
-
1:27:32
target practice: understanding how parp inhibitors take aim at ddr mutations across solid tumors
-
47:27
parp inhibitors: a breakthrough in cancer therapy?
-
47:28
parp inhibitors: a breakthrough in cancer therapy?
-
1:41:03
ovarian cancer symposium 2021: session 2 immunotherapy and targeted therapy
-
1:58
discussing targeted treatment with parp inhibitors for brca-mutant patients across tumor types
-
2:34
ovarian cancer: molecular testing and parp inhibitors
-
10:43
guardantinform™ platform
-
5:13
practical use of parp inhibitors in ovarian cancer
-
48:28
parp inhibitors for the treatment & prevention of hereditary breast & ovarian cancer
-
1:59
eoc: maintenance therapy with parp inhibitors
-
3:44
q&a: what about parp inhibitors?
-
1:24
dr. chagpar on the advances in targeted therapies in breast cancer
-
1:03
project actt - access to cancer testing & treatment in response to covid-19
-
1:17
the complexity of the parp inhibitor landscape in ovarian cancer
-
3:03:33
new strategies for cancer immunotherapy
-
6:37
case 2: sequencing therapy in mcspc